Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.
Tsaur I, Heidegger I, Bektic J, Kafka M, van den Bergh RCN, Hunting JCB, Thomas A, Brandt MP, Höfner T, Debedde E, Thibault C, Ermacora P, Zattoni F, Foti S, Kretschmer A, Ploussard G, Rodler S, von Amsberg G, Tilki D, Surcel C, Rosenzweig B, Gadot M, Gandaglia G, Dotzauer R; EAU-YAU Prostate Cancer Working Party. Tsaur I, et al. Among authors: foti s. Cancer Med. 2021 Sep;10(18):6354-6364. doi: 10.1002/cam4.4184. Epub 2021 Aug 10. Cancer Med. 2021. PMID: 34374489 Free PMC article.
Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment.
Tsaur I, Heidegger I, van den Bergh RCN, Bektic J, Borgmann H, Foti S, Hunting JCB, Kretschmer A, Ploussard G, Tilki D, Gandaglia G, Dotzauer R; EAU-YAU Prostate Cancer Working Party. Tsaur I, et al. Among authors: foti s. Eur Urol Focus. 2021 Nov;7(6):1308-1315. doi: 10.1016/j.euf.2020.06.018. Epub 2020 Jul 9. Eur Urol Focus. 2021. PMID: 32653263
Immunotherapy in small bowel adenocarcinoma: a potential role?
Vitiello F, Cereda S, Foti S, Liscia N, Mazza E, Ronzoni M, Cascinu S. Vitiello F, et al. Among authors: foti s. Immunol Med. 2024 Mar;47(1):1-5. doi: 10.1080/25785826.2023.2220938. Epub 2023 Jun 9. Immunol Med. 2024. PMID: 37293784 Free article. Review.
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide.
Dalla Volta A, Valcamonico F, Zivi A, Procopio G, Sepe P, Del Conte G, Di Meo N, Foti S, Zamboni S, Messina C, Lucchini E, Rizzi A, Ravanelli M, Calza S, Zacchi F, Ciccone G, Suardi N, Maroldi R, Farina D, Berruti A. Dalla Volta A, et al. Among authors: foti s. Eur Urol. 2024 Sep;86(3):268-271. doi: 10.1016/j.eururo.2024.05.004. Epub 2024 May 20. Eur Urol. 2024. PMID: 38772788 No abstract available.
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.
Gregorc V, Novello S, Lazzari C, Barni S, Aieta M, Mencoboni M, Grossi F, De Pas T, de Marinis F, Bearz A, Floriani I, Torri V, Bulotta A, Cattaneo A, Grigorieva J, Tsypin M, Roder J, Doglioni C, Levra MG, Petrelli F, Foti S, Viganò M, Bachi A, Roder H. Gregorc V, et al. Among authors: foti s. Lancet Oncol. 2014 Jun;15(7):713-21. doi: 10.1016/S1470-2045(14)70162-7. Epub 2014 May 13. Lancet Oncol. 2014. PMID: 24831979 Free article. Clinical Trial.
Survival outcomes of Durvalumab in combination to cisplatin and gemcitabine in advanced biliary tract cancer: real world results from a single Italian institution.
Rimini M, Foti S, Camera S, Rossari F, Vitiello F, Lo Prinzi F, Aldrighetti L, De Cobelli F, Pedica F, Arcidiacono PG, Persano M, Cascinu S, Casadei-Gardini A. Rimini M, et al. Among authors: foti s. Oncology. 2024 Dec 6:1-31. doi: 10.1159/000541891. Online ahead of print. Oncology. 2024. PMID: 39647475
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients.
Lo Prinzi F, Rossari F, Silletta M, Foti S, Camera S, Vitiello F, Amadeo E, De Cobelli F, Aldrighetti L, Rimini M, Casadei-Gardini A. Lo Prinzi F, et al. Among authors: foti s. Expert Rev Gastroenterol Hepatol. 2024 Oct;18(10):661-672. doi: 10.1080/17474124.2024.2422367. Epub 2024 Nov 1. Expert Rev Gastroenterol Hepatol. 2024. PMID: 39482984 Review.
152 results